Demineralized bone matrix (DBM) is an osteoinductive biologic material derived from human or animal bone tissues through an acid-extraction process. This extraction process removes the mineral components of bone such as calcium phosphates while leaving behind an organic collagen matrix and osteoinductive non-collagenous proteins. DBM has been widely used in orthopedic and dental applications to promote bone formation and regeneration where bone grafts are required.

Composition and Properties of DBM

Demineralized Bone Matrix is composed primarily of type I collagen which forms the framework or scaffold for new bone growth. It also contains non-collagenous proteins such as bone morphogenetic proteins (BMPs) and growth factors that are responsible for its osteoinductive properties. When implanted into surgical sites, DBM acts as a scaffold that promotes cellular migration, proliferation, and differentiation of mesenchymal stem cells into osteoblasts. This eventual transformation results in new bone formation directly from the DBM putty or particles. Apart from osteoinductivity, DBM also exhibits osteoconductive properties by providing a surface or framework for bone in-growth from surrounding tissues.

Uses of Demineralized Bone Matrix in Orthopedic Surgery

DBM is commonly used as a bone graft substitute or extender in orthopedic procedures such as spinal fusion surgeries and reconstructive hip and knee surgeries. Some examples include:

- Spinal fusion: DBM is utilized as part of interbody fusion devices or combined with bone chips to promote fusion between vertebrae affected by conditions such as degenerative disc disease.

- Total hip replacement: When bone stock is insufficient around the hip joint, DBM can be applied to supplement bone deficiency and stabilize prosthetic implant fixation without the need for autograft.

- Total knee replacement: In knee replacement, DBM putty or strips are used to enhance integration between bone graft and prosthetic components in osteopenic patients.

- Trauma/non-unions: DBM acts as an osteoconductive scaffold at fracture sites to facilitate healing in trauma cases involving delayed unions or non-unions.

Advantages of Demineralized Bone Matrix Over Autograft

DBM possesses several advantages over use of autograft tissue in orthopedic grafting procedures:

- Unlimited supply: DBM is available in unlimited quantities from tissue banks as it can be harvested from multiple donors. This overcomes limited availability of autograft tissue.

- No donor site morbidity: There is no pain, blood loss or potential complications associated with obtaining autograft tissue from patient's own hip or pelvis.

- Sterile processing: DBM undergoes extensive processing to eliminate infectious agents and provide a biosecure sterile graft without disease transmission risk.

- Osteoinductive properties: DBM contains considerably higher levels of osteogenic growth factors compared to demineralized cortical allografts thus enhancing osteoinductivity.

- Cost-effectiveness: DBM made available as ready-to-use graft forms such as strips, putties or pastes eliminates need for surgeon to shape autograft intraoperatively saving time and cost.

Limitations and Research in Demineralized Bone Matrix Formulations

However, DBM does have some drawbacks such as batch-to-batch variability in osteoinductive proteins content depending on tissue source and processing technique. There is ongoing research to develop innovative DBM formulations that deliver consistent osteoinductivity. Some areas of active research include:

- Identification and isolation of key osteoinductive factors like BMP-2, BMP-7 and VEGF proteins.

- Incorporation of osteoinductive factors into DBM scaffolds using gene or protein delivery systems.

- Development of synthetic or natural polymer carriers to provide sustained release of growth factors from DBM.

- Tissue engineering approaches combining DBM, stem cells and growth factors to fabricate robust graft substitutes.

- Clinical studies assessing efficacy of novel DBM formulations containing viable cells or growth factors.

Demineralized bone matrix has emerged as a reliable alternative to autograft in orthopedic applications where new bone formation is required. Further research focused on improving consistency in osteoinductivity promises to enhance the clinical performance of DBM grafts. With its osteoinductive and osteoconductive properties, DBM will likely continue being an essential biologic material for bone regeneration in the future.

Get more insights on Demineralized Bone Matrix

Explore more Articles related Surgical Robots Market

Get More Insights—Access the Report in the Language that Resonates with You

• French
• German
• Italian
• Russian
• Japanese
• Chinese
• Korean
• Portuguese

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.

(https://www.linkedin.com/in/money-singh-590844163)